not suitable for workAugust 25, 2026August 25, 2026By webmaster0 0 Inovio Pharmaceuticals is a single-asset, late-stage biotech, with value hinging on the October 30th PDUFA decision for INO-3107. Learn why INO stock is a hold. Source : seekingalpha.com GB, hinging, INO, Inovio, PDUFA, Pharmaceuticals
Leave a Reply